Onco Sec Medicalorporated logo

ONCS Onco Sec Medicalorporated

OncoSec Medical, Inc. is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.

Healthcare Biotechnology CIK: 1444307 Auditor raised Going Concern issues

Transaction DateRecipientSharesTypePriceValue
Jodie Insights Rating